申请人:Akzo N.V.
公开号:US05180726A1
公开(公告)日:1993-01-19
The invention relates to neuroleptic/antidepressant 4-[4- or 6-(trifluoromethyl)-2-pyridinyl]-1-piperazinylalkyl substituted lactam derivatives having the general structure of formula I: ##STR1## wherein one of the groups R.sub.1 and R.sub.2 is CF.sub.3, and the other is hydrogen or CF.sub.3 ; R.sub.3 is hydrogen or (1-4 C) alkyl; n is an integer from 4 to 5; and m is an integer from 1 to 2; or pharmaceutically acceptable salts thereof. The invention also includes processes for making the compounds and their salts.
本发明涉及一种神经抑制剂/抗抑郁剂,其为4-[4-或6-(三氟甲基)-2-吡啶基]-1-哌嗪基烷基取代内酰胺衍生物,具有公式I的一般结构:##STR1## 其中R.sub.1和R.sub.2中的一个是CF.sub.3,另一个是氢或CF.sub.3;R.sub.3是氢或(1-4 C)烷基;n是4至5的整数;m是1至2的整数;或其药学上可接受的盐。本发明还包括制备该化合物及其盐的方法。